Bright Minds Biosciences Inc. (DRUG) NASDAQ
76.60
-4.42(-5.46%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
76.60
-4.42(-5.46%)
Currency In USD
| Previous Close | 81.02 |
| Open | 80.51 |
| Day High | 80.89 |
| Day Low | 75 |
| 52-Week High | 123.75 |
| 52-Week Low | 23.18 |
| Volume | 429,344.55 |
| Average Volume | 191,028 |
| Market Cap | 594.53M |
| PE | -31.01 |
| EPS | -2.47 |
| Moving Average 50 Days | 82.58 |
| Moving Average 200 Days | 71.33 |
| Change | -4.42 |
Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th
GlobeNewswire Inc.
Sep 19, 2024 2:00 PM GMT
Bright Minds Biosciences announced the initiation of Phase 2 clinical trial of BMB-101 in a group of drug-resistant epilepsies and will discuss the details of the BREAKTHROUGH clinical trial on September 25th.The event will feature Epilepsy KOLs to d